Grant: Undergraduate Student Research Awards (USRA)
University of Toronto
$6,000.00
Developing Lung Metastases in Animal Models for Novel Treatment
FY 2026-27
Summary
Lung metastases occur in a large proportion of patients diagnosed with cancer. The prognosis within this patient population is quite poor. In vivo lung perfusion (IVLP) is a surgical technique developed to allow the targeted delivery of therapeutic agent in high doses to the lungs with minimal systemic exposure. IL-12 shows significant potential for treating and preventing lung metastasis by activating anti-tumor immune responses. Our lab has an ongoing rat study that reproduces lung metastasis with colorectal cancer in the animals and investigates novel therapies via IVLP to treat lung metastasis. This project will contribute to the study by maintaining colorectal cancer cell lines and ensuring reproducible induction of lung metastasis in rats to allow evaluation of novel therapies. Additionally, other types of lung metastasis from different cancer cell lines such as osteosarcoma cell lines will be established to allow investigation of therapies for different patient population. Ultimately, our study will advanced the understanding of metastatic mechanisms and have laid the groundwork for future therapeutic strategies.
Department
Program
Undergraduate Student Research Awards (USRA)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
571669
Name
Powers Kyle
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Developing Lung Metastases in Animal Models for Novel Treatment
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$6,000
Cihrequipment2
$0
Programname2
Undergraduate Student Research Awards (USRA)
Keyworddelim
Cancer; Lung Metastases; N Vivo Lung Perfusion
Abstract
Lung metastases occur in a large proportion of patients diagnosed with cancer. The prognosis within this patient population is quite poor. In vivo lung perfusion (IVLP) is a surgical technique developed to allow the targeted delivery of therapeutic agent in high doses to the lungs with minimal systemic exposure. IL-12 shows significant potential for treating and preventing lung metastasis by activating anti-tumor immune responses. Our lab has an ongoing rat study that reproduces lung metastasis with colorectal cancer in the animals and investigates novel therapies via IVLP to treat lung metastasis. This project will contribute to the study by maintaining colorectal cancer cell lines and ensuring reproducible induction of lung metastasis in rats to allow evaluation of novel therapies. Additionally, other types of lung metastasis from different cancer cell lines such as osteosarcoma cell lines will be established to allow investigation of therapies for different patient population. Ultimately, our study will advanced the understanding of metastatic mechanisms and have laid the groundwork for future therapeutic strategies.
Competitiondate
202605
Approvedterm2
0 yr 4 mths
Pinamesdelim
Powers, Kyle
Approvedterm
0 an 4 mois
Cihrcontribution2
~ $6,000~ $0~